The trademark application ASPYRERX was filed by Click Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 2, 2023, and it was registered by office on February 9, 2024 without any oppositions.
The application was filed in English (Italian was selected as the second language).
A transfer of the trademark registration was recorded on October 15, 2024.
Goods And Services
The mark was filed in class 9 with following description of goods:
Downloadable mobile medical application (MMA) for the treatment and management of cardiometabolic diseases and conditions
Downloadable MMA prescribed by physicians for the treatment of cardiometabolic diseases and conditions
Downloadable MMA delivering Cognitive Behavioral Therapy (CBT) for the management and treatment of cardiometabolic diseases
Downloadable software as a medical device for the treatment of patients with cardiometabolic diseases and conditions
Downloadable software application, namely, a prescription digital therapeutic providing cognitive behavioral therapy for the treatment of cardiometabolic diseases and conditions
Downloadable software for collecting self-reported biometric data and information from patients for the treatment of cardiometabolic diseases and conditions.